Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Medicines register
Registers› Irish medicines ›Co-amoxiclav 875mg/125mg Film-coated Tablets
Medicines register · Ireland

Co-amoxiclav 875mg/125mg Film-coated Tablets

Authorisation PA23148/004/003 · Brown & Burk IR Limited

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
Brown & Burk IR Limited (all products →)
Active substances
Amoxicillin, Clavulanic acid
Clinical trials
30 clinical trials →
Dosage form
Film-coated tablet
Route of administration
Oral use
ATC codes
J01CA, J01CA04
First authorised
09/03/2012
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Generic application (Article 10(1) of Directive No 2001/83/EC)

Amoxicillin: supply and approvals

40 authorised products on the HPRA list contain Amoxicillin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
Amoxicillin and amoxicillin/clavulanic acid: Shortage resolved, first published 27 Jan 2023
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
3 supply notices, e.g. Amoxicillin AL TS (1 May 2024 to 1 Dec 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Clavulanic acid: supply and approvals

25 authorised products on the HPRA list contain Clavulanic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
Amoxicillin and amoxicillin/clavulanic acid: Shortage resolved, first published 27 Jan 2023
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 14 years (since 9 March 2012). The HPRA list marks it as marketed in Ireland.

Other medicines with Amoxicillin in Ireland

35 other products on the HPRA list contain Amoxicillin, from 13 licence holders; 28 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Amoclav 500mg/125mg Film-coated tabletsRowex Limited,National authorisation (PA)Marketed
Amoxicillin 250 mg hard capsulesClonmel Healthcare LtdNational authorisation (PA)Marketed
Amoxicillin 250 mg/5 ml powder for oral suspensionClonmel Healthcare LtdNational authorisation (PA)Marketed
Amoxicillin 500 mg hard capsulesClonmel Healthcare LtdNational authorisation (PA)Marketed
Amoxicillin Delbert 500 mg powder for solution for injection or infusionLaboratoires DELBERTNational authorisation (PA)Marketed
Augmentin 250 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin 500 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin 875 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Clavamel Forte 500mg/125mg film-coated tabletClonmel Healthcare LtdNational authorisation (PA)Marketed
Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral SuspensionBrown & Burk IR LimitedNational authorisation (PA)Marketed

All 36 products with Amoxicillin →

Other medicines with Clavulanic acid in Ireland

24 other products on the HPRA list contain Clavulanic acid, from 11 licence holders; 20 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Amoclav 500mg/125mg Film-coated tabletsRowex Limited,National authorisation (PA)Marketed
Augmentin 250 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin 500 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin 875 mg/125 mg film-coated tabletsGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Clavamel Forte 500mg/125mg film-coated tabletClonmel Healthcare LtdNational authorisation (PA)Marketed
Co-Amoxiclav Sugar Free 400 mg/57 mg/5 ml Powder for Oral SuspensionBrown & Burk IR LimitedNational authorisation (PA)Marketed
Co-Amoxiclav TEVA 1000 mg/200 mg Powder for Solution for Injection/InfusionTeva Pharma B.V.National authorisation (PA)Marketed
Co-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/InfusionTeva Pharma B.V.National authorisation (PA)Marketed
Co-amoxiclav 1000 mg/200 mg powder for solution for injection/infusionInstituto Biochimico Italiano G. Lorenzini S.p.A.National authorisation (PA)Marketed
Co-amoxiclav 1000mg/200mg powder for solution for injection/infusionFresenius Kabi Deutschland GmbHNational authorisation (PA)Marketed

All 25 products with Clavulanic acid →

Other substances in ATC group J01CA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group J01CA with this product:

Amoxicillin (as trihydrate) (1) · Pivmecillinam hydrochloride (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Brown & Burk IR Limited holds 15 products on the HPRA list, with 10 different active substances; 9 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.